ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

INCY Incyte Corporation

58,52
0,11 (0,19%)
08 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Incyte Corporation INCY NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,11 0,19% 58,52 00:29:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
58,14 58,02 59,24 59,16 58,41
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
07.6.202422:30BWIncyte Reports Inducement Grants Under Nasdaq Listing Rule..
06.6.202422:40EDGAR2Form 144 - Report of proposed sale of securities
04.6.202423:29EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
30.5.202422:05BWIncyte Completes Acquisition of Escient Pharmaceuticals
30.5.202421:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21.5.202419:15BWIncyte Expands Presence in Delaware through Acquisition of..
21.5.202414:00BWIncyte to Present at Upcoming Investor Conference
16.5.202403:45BWIncyte präsentiert Daten aus seinem Onkologie-Portfolio beim..
15.5.202417:44BWIncyte présentera les données de son portefeuille..
15.5.202417:10EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
14.5.202423:00BWIncyte to Highlight Data From its Oncology Portfolio at the..
14.5.202415:05IHMARKETNEWSProducer Price Inflation Data May Weigh On Wall Street
14.5.202400:06EDGAR2Form SC 13D/A - General statement of acquisition of..
13.5.202422:34IHMARKETNEWSDow Snaps Eight-Day Winning Streak After Lackluster Session
13.5.202417:19EDGAR2Form SC TO-I - Tender offer statement by Issuer
13.5.202413:19EDGAR2Form SC TO-C - Written communication relating to an issuer..
13.5.202413:18EDGAR2Form 8-K - Current report
13.5.202413:00BWIncyte Announces Intention to Buy Back up to $2.0 Billion of..
10.5.202400:40EDGAR2Form SC 13D/A - General statement of acquisition of..
10.5.202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.5.202414:00BWIncyte to Present at Upcoming Investor Conference
30.4.202413:00BWIncyte Reports 2024 First Quarter Financial Results and..
24.4.202400:11BWIncyte annonce l'acquisition d'Escient Pharmaceuticals et de..
24.4.202400:01BWIncyte gibt Übernahme von Escient Pharmaceuticals und dessen..
23.4.202413:00BWIncyte Announces Acquisition of Escient Pharmaceuticals and..
11.4.202414:00BWIncyte to Report First Quarter Financial Results
01.4.202414:30BWIncyte and CMS Announce Collaboration and License Agreement..
29.3.202421:30BWIncyte Reports Inducement Grant Under Nasdaq Listing Rule..
11.3.202413:57BWIncyte gibt neue Daten aus Phase-2-Studie zur Untersuchung..
11.3.202411:06BWIncyte présente de nouvelles données de l’étude de phase 2..
11.3.202410:53BWIncyte legt neue brandaktuelle Daten aus Phase-2-Studie zur..
10.3.202421:05BWIncyte Announces New Data from Phase 2 Study Evaluating..
04.3.202420:38BWDe nouvelles données dérivées du portefeuille dermatologique..
04.3.202420:02BWNeue Daten aus dem wachsenden Dermatologieportfolio von..
04.3.202414:00BWNew Data from Incyte’s Growing Dermatology Portfolio to be..
29.2.202416:19BWIncyte Launches The Unseen Journey to Elevate the Hidden..
29.2.202413:30GLOBEKnight Therapeutics Announces Launch of Minjuvi® in Brazil
28.2.202415:11BWIncyte annonce que la Food and Drug Administration des..
28.2.202413:15BWIncyte gibt bekannt, dass die US-Arzneimittelbehörde FDA..
27.2.202422:08BWIncyte Announces U.S. Food and Drug Administration Grants..
16.2.202422:04EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
16.2.202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202418:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202414:00BWIncyte to Present at Upcoming Investor Conference
14.2.202418:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202423:06EDGAR2Form S-8 - Securities to be offered to employees in employee..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock